Department of Internal Medicine, Division of Endocrinology, Texas Tech University Health Science Center, Lubbock, Texas.
Department of Internal Medicine, Texas Tech University Health Science Center, Lubbock, Texas.
Endocr Pract. 2020 Jul;26(7):699-706. doi: 10.4158/EP-2019-0454. Epub 2020 Nov 24.
Thyrotoxic periodic paralysis (TPP) is a muscular disorder characterized by sudden episodes of muscle weakness and hypokalemia in the setting of thyrotoxicosis. We aimed to report our experience with TPP in West Texas and compare its clinical presentation to that of patients admitted for complicated thyrotoxicosis.
Retrospective review of records of adult patients with admission diagnosis of hyperthyroidism, thyrotoxicosis, and/or discharge diagnosis of periodic paralysis seen at our institution in a 6-year period.
Patients admitted for complicated thyrotoxicosis were more commonly females of a mean age of 44 years. Patients with TPP were more commonly Hispanic males of a mean age of 27 years. Despite no significantly different thyroid hormone levels, patients with TPP presented with less-severe signs and symptoms of hyperthyroidism, as reflected by lower Burch-Wartofsky score on admission (19 vs. 35; P<.001) and lower occurrence of atrial fibrillation in the TPP group (0% vs. 36%; P<.001). Finally, 89% of TPP patients presented with corrected QT (QTc) prolongation, whereas only 19% of thyrotoxic patient presented with a prolonged QTc.
Hispanic patients with TTP seems to have relative resistance to the actions of thyroid hormones and commonly present with QTc prolongation, a risk factor for cardiac arrhythmias.
BWS = Burch-Wartofsky point scale; EKG = electrocardiogram; FT3 = free triiodothyronine; FT4 = free thyroxine; ICD = International Classification of Diseases; QTc = corrected QT; TPP = thyrotoxic periodic paralysis.
甲状腺毒症周期性瘫痪(TPP)是一种以甲状腺毒症时突然出现肌肉无力和低钾血症为特征的肌肉疾病。我们旨在报告我们在德克萨斯州西部的 TPP 经验,并将其临床表现与因复杂甲状腺毒症住院的患者进行比较。
回顾性分析我院 6 年内入院诊断为甲状腺功能亢进症、甲状腺毒症和/或出院诊断为周期性瘫痪的成年患者的病历。
因复杂甲状腺毒症住院的患者多为女性,平均年龄为 44 岁。TPP 患者多为 Hispanic 男性,平均年龄为 27 岁。尽管甲状腺激素水平无显著差异,但 TPP 患者的甲状腺毒症表现较轻,入院时 Burch-Wartofsky 评分较低(19 分比 35 分;P<.001),心房颤动发生率较低(0%比 36%;P<.001)。最后,89%的 TPP 患者出现校正 QT(QTc)延长,而只有 19%的甲状腺毒症患者出现 QTc 延长。
Hispanic TTP 患者似乎对甲状腺激素的作用有一定的抵抗力,常见 QTc 延长,这是心律失常的一个危险因素。
BWS = Burch-Wartofsky 评分;EKG = 心电图;FT3 = 游离三碘甲状腺原氨酸;FT4 = 游离甲状腺素;ICD = 国际疾病分类;QTc = 校正 QT;TPP = 甲状腺毒症周期性瘫痪。